According to a recent study, guselkumab is effective in treating moderate-to-severe scalp psoriasis in patients with Fitzpatrick Skin Types IV through VI.
GPP patients have five times higher mortality risk than those without
According to a recent study, patients with generalized pustular psoriasis (GPP) have a five times higher risk of all-cause mortality at one year than those without GPP.
Pediatric HS patients have increased prevalence of chronic medical, psychiatric comorbidities
According to a recent study, pediatric patients with hidradenitis suppurativa (HS) have an increased prevalence of chronic medical and psychiatric comorbidities when compared to patients without HS.
Study shows stigma drives depression more than disease severity in alopecia patients
According to a recent study, stigma around alopecia causes more depression and anxiety than the disease itself.
Biologic therapy linked to increased risk of superficial fungal infection in PsO patients
According to a recent study, biologic treatment of psoriasis (PsO) can raise the risk of superficial fungal infections in patients, especially with interleukin (IL)-17 inhibitors.
Study shows ivarmacitinib safe, efficacious in treating moderate-to-severe AD
According to a recent study, ivarmacitinib, a Januse kinase (JAK)-1 inhibitor, has been shown to be effective and safe in treating adolescent and adult patients with atopic dermatitis (AD).
Oral nutraceutical may improve skin health, acne in adult women
According to a recent study, a novel oral nutraceutical may improve skin health and mild-to-moderate acne in women.
AI model may assist clinicians with skin cancer diagnoses
According to a recent study, PanDerm, an AI model built specifically to assist with real-world dermatology practices, may benefit both dermatologists and clinicians in skin cancer diagnoses.
TikTok teen skin-care routines offer little benefit to pediatric populations
According to a recent study, teen skin-care routines shared by influencers on the social media platform TikTok offer no real benefit to pediatric populations and include ingredients that aggravate the skin.
One-third of PsO patients on biologics experience residual inflammation
According to a recent study, more than one-third of psoriasis patients on biologics still have increased inflammatory markers in their blood.
HealthMinute.TV 